We are delighted to be working with BioEden and to provide this invaluable service to our Members. Stem cell science is progressing at an unprecedented pace and we are confident that stem cell therapy will become a mainstream part of care.
(PRWEB UK) 14 October 2015
A prestigious International Private Health provider is promoting stem cell banking from naturally shed baby teeth. The move by this leading healthcare provider aims to reduce the cost of client premiums to its members over the longer term by having stem cells readily available for each individual. Each member who takes advantage of this opportunity will have their own stem cells stored for life, eliminating the need to search for a donor match and a lifetime of anti-rejection drugs if therapy is needed.
The company selected by Medicover are BioEden, a specialist tooth stem cell company who operate in over 20 countries and lead the market both in terms of volume and quality. In fact it was BioEden’s chief scientist who pioneered the process, a process which holds the only patent in the world. Best of all, the stem cells are taken from naturally shed baby teeth, as the BioEden process requires no medical or dental intervention and so is pain free and entirely natural.
Medicover today announced that they will be promoting the services of pioneering stem cell bank BioEden to its entire client base, and by doing so will further demonstrate their commitment to the best in healthcare to its Members.
John Stubbington, Chief Operating Officer at Medicover said, ‘We are delighted to be working with BioEden and to provide this invaluable service to our Members. Stem cell science is progressing at an unprecedented pace and we are confident that stem cell therapy will become a mainstream part of care. My daughters own stem cells are banked with BioEden, and having used the service I am proud to say that BioEden has the same passion for quality as the Medicover Group’.
Medicover is a company who are dedicated to providing the best in healthcare to its members. Medicover was established over 20 years ago in Poland and today operates in 13 countries.
BioEden’s Group CEO, Tony Veverka said ‘ I am delighted to be working with Medicover, we share the same values, and they clearly understand the key role stem cell therapy will play within healthcare going forward. Medicover services are designed to improve the quality of their Members lives. BioEden’s service provides the perfect fit to Medicover, a company who prides itself in innovative, forward thinking excellence in care.